The Metis Foundation
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, The Metis Foundation sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
The Metis Foundation: 8 sponsored US clinical trials, 2 recruiting.
The Metis Foundation sponsors 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 5 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Burns, with 2 trials.
Upper-quartile sponsor footprint
The Metis Foundation sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds
NCT05462860
Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers
NCT05217160
Assessment Of Burn Severity and Extent Spatial Frequency Domain Imaging
NCT06921421
A Case-Control Study of Negative Pressure Platform Wound Devices (NP-PWD) for Skin and Soft Tissue Defects
NCT06552481
The Use of a Platform Wound Device for Reducing Infection
NCT04753723
A Case Series Study of Negative Pressure Platform Wound Device
NCT04080011
Procellera® Compared to Standard of Care Treatment in Mitigating Biofilm Formation in Acute Trauma and Burn Wounds
NCT04079998
Effects of Pulsed Dye and CO2 Laser in Treatment of Hypertrophic Burn Scars.
NCT04769089
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 2 |
Therapeutic Areas
Where The Metis Foundation enrollment is open (later-stage tilt)
2 recruiting of 8 indexed (25% open); 5 completed (63%).
Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Burns (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The Metis Foundation: open-pipeline peers nationwide
Peers matched on 8 registered trials and 25% open enrollment, not the therapeutic-area sidebar.
The Metis Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 25% open enrollment (± trial volume)
- Abdul Latif Jameel Poverty Action Lab · 25% recruiting · 4 trials
- Accutar Biotechnology · 25% recruiting · 4 trials
- Adrienne G. Waks · 25% recruiting · 4 trials
- Advocate Hospital System · 25% recruiting · 4 trials
Related
What to do with this The Metis Foundation page
8 registered trials is a research-attention snapshot, not an endorsement of The Metis Foundation or any single study.
- 2 of The Metis Foundation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Burns is the condition The Metis Foundation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Burns trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
The Metis Foundation pipeline card: 8 registered trials from official public datasets.Report a data error.